{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:51:22Z","timestamp":1783651882103,"version":"3.55.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007350","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["247164"],"award-info":[{"award-number":["247164"]}],"id":[{"id":"10.13039\/501100007350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00242","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T07:33:38Z","timestamp":1527579218000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema"],"prefix":"10.3389","volume":"9","author":[{"given":"Ma. Ludivina","family":"Robles-Osorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Garc\u00eda-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos D.","family":"N\u00fa\u00f1ez-Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena","family":"Mira-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Ram\u00edrez-Neria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellery","family":"L\u00f3pez-Star","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bertsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Mart\u00ednez de la Escalera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Triebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Clapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/archophthalmol.2009.172","article-title":"The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy","volume":"127","author":"Klein","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2337\/db07-1618","article-title":"Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2014revisited","volume":"57","author":"Lachin","year":"2008","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-59745-563-3_3","article-title":"The epidemiology of diabetic retinopathy","volume-title":"Diabetic Retinopathy","author":"Klein","year":"2008"},{"key":"B7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/2042018813512360","article-title":"Anti-vascular endothelial growth factor therapy for diabetic macular edema","volume":"4","author":"Boyer","year":"2013","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-319-12114-7_4","article-title":"Regulation of blood vessels by prolactin and vasoinhibins","volume":"846","author":"Clapp","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"R1193","DOI":"10.1152\/ajpregu.00256.2015","article-title":"Principles of the prolactin\/vasoinhibin axis","volume":"309","author":"Triebel","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B10","first-page":"2498","article-title":"Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules","volume":"40","author":"Duenas","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1167\/iovs.05-0173","article-title":"Prolactins are natural inhibitors of angiogenesis in the retina","volume":"46","author":"Aranda","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/pr.2016.241","article-title":"Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity","volume":"81","author":"Zepeda-Romero","year":"2017","journal-title":"Pediatr Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1002\/iub.518","article-title":"Prolactin and vasoinhibins: endogenous players in diabetic retinopathy","volume":"63","author":"Triebel","year":"2011","journal-title":"IUBMB Life"},{"key":"B14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1530\/EJE-09-0130","article-title":"Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy","volume":"161","author":"Triebel","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.2337\/db10-0873","article-title":"High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins","volume":"59","author":"Arnold","year":"2010","journal-title":"Diabetes"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1167\/iovs.03-1001","article-title":"Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice","volume":"45","author":"Pan","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1172\/JCI34508","article-title":"Vasoinhibins prevent retinal vasopermeability associated with diabetic retinopathy in rats via protein phosphatase 2A-dependent eNOS inactivation","volume":"118","author":"Garcia","year":"2008","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","first-page":"8944","DOI":"10.1167\/iovs.11-8190","article-title":"Vasoinhibin gene transfer by adenoassociated virus type 2 protects against VEGF- and diabetes-induced retinal vasopermeability","volume":"52","author":"Ramirez","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/labinvest.2015.135","article-title":"Diabetes enhances the efficacy of AAV2 vectors in the retina: therapeutic effect of AAV2 encoding vasoinhibin and soluble VEGF receptor 1","volume":"96","author":"Diaz-Lezama","year":"2016","journal-title":"Lab Invest"},{"key":"B20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3389\/fncel.2014.00333","article-title":"Vasoinhibins regulate the inner and outer blood-retinal barrier and limit retinal oxidative stress","volume":"8","author":"Arredondo Zamarripa","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.2337\/db05-1635","article-title":"Diabetic retinopathy: seeing beyond glucose-induced microvascular disease","volume":"55","author":"Antonetti","year":"2006","journal-title":"Diabetes"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1523\/JNEUROSCI.2452-13.2014","article-title":"The hormone prolactin is a novel, endogenous trophic factor able to regulate reactive glia and to limit retinal degeneration","volume":"34","author":"Arnold","year":"2014","journal-title":"J Neurosci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.4088\/JCP.13f08510","article-title":"Low-dose amisulpride and elevation in serum prolactin","volume":"74","author":"Andrade","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"B24","first-page":"1989","article-title":"Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis","volume":"90","author":"Mansi","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/gut.2009.199703","article-title":"Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years","volume":"59","author":"Kashyap","year":"2010","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2036.2004.01867.x","article-title":"Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics","volume":"19","author":"Tonini","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"372","author":"Wells","year":"2015","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"8234186","DOI":"10.1155\/2017\/8234186","article-title":"Update on diagnosis and treatment of diabetic retinopathy: a consensus guideline of the Working Group of Ocular Health (Spanish Society of Diabetes and Spanish Vitreous and Retina Society)","volume":"2017","author":"Corcostegui","year":"2017","journal-title":"J Ophthalmol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"11045","DOI":"10.1158\/0008-5472.CAN-07-0986","article-title":"16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"CD008081","DOI":"10.1002\/14651858.CD008081.pub2","article-title":"Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy","author":"Virgili","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med"},{"key":"B33","volume-title":"Sample Size Calculations in Clinical Research","author":"Chow","year":"2008"},{"key":"B34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/jamaophthalmol.2015.4599","article-title":"Association of baseline visual acuity and retinal thickness with 1-year efficacy of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema","volume":"134","author":"Wells","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0011-393X(05)80656-3","article-title":"The clinical use of levosulpiride","volume":"53","author":"Guslandi","year":"1993","journal-title":"Curr Ther Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2147\/tcrm.2007.3.1.149","article-title":"Effectiveness and safety of levosulpiride in the treatment of dysmotility-like functional dyspepsia","volume":"3","author":"Lozano","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1124\/jpet.102.035303","article-title":"The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats","volume":"302","author":"Kapur","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2125.1987.tb03153.x","article-title":"Prolactin response to low dose sulpiride","volume":"24","author":"McMurdo","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4103\/ijem.IJEM_555_16","article-title":"Levosulpiride and serum prolactin levels","volume":"21","author":"Kuchay","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/0269881112442016","article-title":"Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis","volume":"26","author":"Cookson","year":"2012","journal-title":"J Psychopharmacol"},{"key":"B41","first-page":"317","article-title":"Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial","volume":"28","author":"Corazza","year":"1996","journal-title":"Ital J Gastroenterol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2337\/diab.2.1.7","article-title":"Recovery from retinopathy in a case of diabetes with Simmonds\u2019 disease","volume":"2","author":"Poulsen","year":"1953","journal-title":"Diabetes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJM196610272751703","article-title":"Growth hormone in relation to diabetic retinopathy","volume":"275","author":"Powell","year":"1966","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000168456","article-title":"Hypopituitarism stabilizes the renal and retinal complications of diabetes mellitus","volume":"12","author":"Plumb","year":"1992","journal-title":"Am J Nephrol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000438970","article-title":"Diabetic retinopathy and diabetic macular edema","volume":"55","author":"Cohen","year":"2016","journal-title":"Dev Ophthalmol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ebiom.2016.03.048","article-title":"Prolactin protects retinal pigment epithelium by inhibiting sirtuin 2-dependent cell death","volume":"7","author":"Melendez Garcia","year":"2016","journal-title":"EBioMedicine"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00242\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T07:33:44Z","timestamp":1527579224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00242\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":46,"alternative-id":["10.3389\/fendo.2018.00242"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00242","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]},"article-number":"242"}}